Schiffgens, S., Wilkens, L., Brandes, A. A., Meier, T., Franceschi, E., Ermani, M., . . . Dumitru, C. A. (2016). Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma. Oncotarget.
Citação norma ChicagoSchiffgens, Salveena, Ludwig Wilkens, Alba A. Brandes, Tatiana Meier, Enrico Franceschi, Mario Ermani, Christian Hartmann, Ibrahim Erol Sandalcioglu, and Claudia A. Dumitru. "Sex-specific Clinicopathological Significance of Novel (Frizzled-7) and Established (MGMT, IDH1) Biomarkers in Glioblastoma." Oncotarget 2016.
Citação norma MLASchiffgens, Salveena, et al. "Sex-specific Clinicopathological Significance of Novel (Frizzled-7) and Established (MGMT, IDH1) Biomarkers in Glioblastoma." Oncotarget 2016.